Idevax
PrivateLast Round
Series A
Oct 24, 2024
Total Funding Raised
$9.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Idevax operates in Healthcare & Life Sciences and is based in Antwerp. Its latest recorded funding round was a Series A round in October 2024.
Idevax is a medical device company that develops, produces, and commercializes innovative skin drug delivery devices for prophylactic and therapeutic vaccination and immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Idevax Comparables
Compare Idevax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latch Medical Limited | 87% | |
| NanoPass Technologies Ltd. | 82% | |
| Satio | 77% |
For institutional investors. Book with your work email.
Idevax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 24, 2024 | ||||
| Seed | Jan 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Idevax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VLAIO | Seed |
| Myosotis Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 523% MoM, reaching 4.4K.
- Apr 21, 2026
Monthly visitors grew 228% MoM, reaching 2.8K.
For institutional investors. Book with your work email.
Idevax Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Idevax's valuation, stock price, and market status.
Is Idevax a public or private company?
Idevax is a private company.
What is the current stock price of Idevax?
Idevax is a private company, so its shares have no public market price. Caplight tracks Idevax's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Idevax worth (valuation)?
Valuation information for Idevax is not publicly available.
Can I buy Idevax stock?
Idevax shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Idevax's last funding round?
Idevax's most recent funding round was Series A on October 24, 2024.
Who are the main investors in Idevax?
Key investors in Idevax include Myosotis Investments.
Will Idevax IPO soon?
No public IPO plans have been announced for Idevax.
How can I track Idevax secondary market activity?
Caplight tracks bids, offers, and trades in Idevax's shares on secondary markets.